Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript
Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.48, expectations were $0.46.
Bio-Techne Corp (TECH)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Lee Munder Capital Group Lee Munder | 13,106 | $922,531 | -45% | 0.05% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $352.55 | 300 | 10,106 | 2022-05-10 | Filing | ||
| $185.00 | 100 | Officer, Director | 100 | 2019-09-09 | Filing | |
| $185.00 | 100 | Officer, Director | 100 | 2019-09-09 | Filing | |
| $191.06 | 500 | Director | 8,726 | 2019-08-07 | Filing | |
| $65.00 | 2,361 | Director | 70,000 | 2013-05-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $76.98 | 10,400 | Director | 43,097 | 2024-03-07 | Filing | |
| $80.32 | 8,939 | Director | 51,872 | 2023-08-30 | Filing | |
| $88.36 | 80,000 | Officer, Director | 1,258,766 | 2023-07-21 | Filing | |
| $83.00 | 322 | Officer, Director | 1,112,817 | 2023-06-07 | Filing | |
| $82.12 | 7,450 | 26,092 | 2022-12-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 18,228,210 | $1,406,488,683 | 0.03% | |
| 2. | 18,133,912 | $1,399,212,623 | 0.03% | |
| 3. | 6,328,129 | $488,278,434 | 0.02% | |
| 4. | 5,352,006 | $412,960,783 | 1.09% | |
| 5. | 4,088,095 | $315,437,590 | 0.02% |
News See All
Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript
Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.48, expectations were $0.46.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
What Makes Bio-Techne Corporation (TECH) an Investment Bet?
Polen Capital, an investment management company, released its “Polen U.S. SMID Company Growth Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
Bio-Techne Corporation (NASDAQ:TECH) Q2 2024 Earnings Call Transcript
Bio-Techne Corporation misses on earnings expectations. Reported EPS is $0.4 EPS, expectations were $0.42.
Should You Hold Bio-Techne Corporation (TECH) For the Long Term?
Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
Bio-Techne Corporation (NASDAQ:TECH) Q1 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Bio-Techne Earnings Conference Call for the First Quarter of Fiscal Year 2024.
Various Headwinds Pressured Bio-Techne Corporation (TECH) Shares in Q3
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
Bio-Techne Corporation (NASDAQ:TECH) Q4 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Fourth Quarter of Fiscal Year 2023.
Should You Hold Bio-Techne Corp. (TECH)?
Conestoga Capital Advisors, an asset management company, released its “Mid Cap Strategy” first-quarter 2023 investor letter. A copy of the same can be downloaded here.
Billionaire Hedge Funds
